Chronic administration of GBP over a period of 2 weeks does not cause changes in BDNF expression in the ipsilateral dorsal horn of the lumbar spinal cord in animal models of neuropathic pain (Vanelderen et al., 2013). The gene discussed is BDNF; the disease is neuropathic pain.